ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
2,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
3,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
3,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
3,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
3,4,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
4,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
5,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
5,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
6,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,2,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
7,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
8,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
8,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,3,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,4,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
8,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
8,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
9,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
10,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
10,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
11,1,Leukaemic infiltration hepatic,Leukaemias NEC,Leukaemias,Neopl,N
12,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
12,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
14,2,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
14,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
16,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
17,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
17,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
18,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
19,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
20,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
20,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
21,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
21,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
21,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
21,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
22,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
23,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
24,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
24,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
25,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
25,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
26,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
26,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
29,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
30,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
31,1,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
31,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
32,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
32,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
33,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
33,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
33,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
33,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
33,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,6,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
33,7,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
33,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,9,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,10,Posturing,Stereotypies and automatisms,Changes in physical activity,Psych,N
33,11,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
33,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
35,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
36,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
36,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
36,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
37,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
37,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
38,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
38,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
39,1,Vascular device occlusion,Vascular complications associated with device,Complications associated with device,Genrl,N
40,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
41,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
41,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
41,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
41,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
41,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
42,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
42,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
43,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,Y
44,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
45,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
46,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
48,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
49,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
49,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,3,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
49,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
51,1,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
52,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
53,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
54,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
55,1,Gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
55,2,Transformation to acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
56,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
57,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
57,2,Chimerism,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
57,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
58,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
59,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
59,2,Transformation to acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
60,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
60,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
